A new study reveals that only about 1 in 3 patients with prostate cancer have a successful first CT simulation, while 1 in 6 need to be rescheduled for another day.

Superior molecular pathology of urothelial bladder cancer using urinary cell-free DNA. Impact of primary tumor location, histology, and host factors on objective response to immune checkpoint ...

Patient preferences for clinical attributes of metastatic melanoma treatment with targeted therapy and immunotherapy. In a patient with newly diagnosed metastatic melanoma, 25% of oncologists did not ...

Understanding the principles of cancer evolution is important in designing a therapeutic strategy. A research group at The Institute of Medical Science, The University of Tokyo (IMSUT) announced a new ...